{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T21:23:25Z","timestamp":1791753805255,"version":"4.3.4"},"reference-count":36,"publisher":"American Society of Hematology","issue":"3","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2003,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Current immunotherapeutic trials for patients with multiple myeloma (MM) focus on the idiotype (Id) as a tumor-specific antigen for active immunization. To bypass the need for the identification of shared MM-associated antigens and the characterization of possible immunogenic T-cell epitopes in a human leukocyte antigen (HLA) type\u2013restricted manner, we focused on myeloma RNA transfection of dendritic cells (DCs). Total RNA encodes the whole antigen content of tumor cells, therefore allowing the transfected DCs to process and present the most relevant peptides and to induce a possible polyclonal cytotoxic T lymphocyte (CTL) response against different immunogenic antigens. We transfected monocyte-derived DCs with total RNA from the myeloma cell lines LP-1 and U266 by electroporation and investigated the potential of these DCs to induce myeloma-specific CTLs. We show that RNA-transfected DCs induce CTLs that lyse the LP-1 and U266 myeloma cells in an antigen-specific and major histocompatibility complex (MHC) class I\u2013restricted manner, as demonstrated by cold-target inhibition and antibody-blocking studies. Interestingly, LP-1\u2013specific CTLs showed no specificity for the idiotype. Consistent with studies demonstrating mucin 1 (MUC1) as a myeloma-associated antigen, we found MUC1 specificity of the CTLs induced with U266-derived RNA. As corresponding epitopes, we tested the described peptides M1.1 and M1.2 and found a striking fine specificity for M1.2, assuming a possible immunodominance of this peptide. This is the first report on the induction of myeloma-specific CTLs by RNA transfection of DCs.<\/jats:p>","DOI":"10.1182\/blood-2002-04-1273","type":"journal-article","created":{"date-parts":[[2003,1,15]],"date-time":"2003-01-15T21:05:10Z","timestamp":1042664710000},"page":"977-982","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":90,"title":["Induction of myeloma-specific cytotoxic T cells using dendritic cells transfected with tumor-derived RNA"],"prefix":"10.1182","volume":"101","author":[{"given":"Caterina","family":"Milazzo","sequence":"first","affiliation":[{"name":"From the Department of Hematology, Oncology, Immunology, and Rheumatology, University of Tu\u0308bingen, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker L.","family":"Reichardt","sequence":"additional","affiliation":[{"name":"From the Department of Hematology, Oncology, Immunology, and Rheumatology, University of Tu\u0308bingen, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin R.","family":"Mu\u0308ller","sequence":"additional","affiliation":[{"name":"From the Department of Hematology, Oncology, Immunology, and Rheumatology, University of Tu\u0308bingen, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Gru\u0308nebach","sequence":"additional","affiliation":[{"name":"From the Department of Hematology, Oncology, Immunology, and Rheumatology, University of Tu\u0308bingen, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Brossart","sequence":"additional","affiliation":[{"name":"From the Department of Hematology, Oncology, Immunology, and Rheumatology, University of Tu\u0308bingen, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111616325228100_B1","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nm0398-328","article-title":"Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells.","volume":"4","author":"Nestle","year":"1998","journal-title":"Nat Med."},{"key":"2019111616325228100_B2","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/(SICI)1097-0045(19990401)39:1<54::AID-PROS9>3.0.CO;2-U","article-title":"Phase II prostate cancer vaccine trial: report of a study involving 37 patients with disease recurrence following primary treatment.","volume":"39","author":"Murphy","year":"1999","journal-title":"Prostate."},{"key":"2019111616325228100_B3","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/00002371-200007000-00013","article-title":"Phase 1 study in patients with metastatic melanoma of immunization with dendritic cells presenting epitopes derived from the melanoma-associated antigens MART-1 and gp100.","volume":"23","author":"Panelli","year":"2000","journal-title":"J Immunother."},{"key":"2019111616325228100_B4","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJM199210223271705","article-title":"Induction of immune responses in patients with B-cell lymphoma against the surface-immunoglobulin idiotype expressed by their tumors.","volume":"327","author":"Kwak","year":"1992","journal-title":"N Engl J Med."},{"key":"2019111616325228100_B5","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1182\/blood.V89.9.3129","article-title":"Tumor-specific idiotype vaccines in the treatment of patients with B-cell lymphoma: long-term results of a clinical trial.","volume":"89","author":"Hsu","year":"1997","journal-title":"Blood."},{"key":"2019111616325228100_B6","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1038\/13928","article-title":"Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma.","volume":"5","author":"Bendandi","year":"1999","journal-title":"Nat Med."},{"key":"2019111616325228100_B7","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1182\/blood.V91.7.2459","article-title":"Idiotype immunization combined with granulocyte-macrophage colony-stimulating factor in myeloma patients induced type I, major histocompatibility complex-restricted, CD8- and CD4-specific T-cell responses.","volume":"91","author":"O\u0308sterborg","year":"1998","journal-title":"Blood."},{"key":"2019111616325228100_B8","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1182\/blood.V94.2.673","article-title":"Idiotype vaccination in human myeloma: generation of tumor-specific immune responses after high-dose chemotherapy.","volume":"94","author":"Massaia","year":"1999","journal-title":"Blood."},{"key":"2019111616325228100_B9","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1182\/blood.V93.7.2411","article-title":"Idiotype vaccination using dendritic cells after autologous peripheral blood stem cell transplantation for multiple myeloma: a feasibility study.","volume":"93","author":"Reichardt","year":"1999","journal-title":"Blood."},{"key":"2019111616325228100_B10","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S1083-8791(00)70027-9","article-title":"Idiotype vaccination using dendritic cells after autologous peripheral blood progenitor cell transplantation for multiple myeloma.","volume":"6","author":"Liso","year":"2000","journal-title":"Biol Blood Marrow Transplant."},{"key":"2019111616325228100_B11","first-page":"378a","article-title":"Specific immunotherapy of multiple myeloma patients using idiotype pulsed serum free generated dendritic cells [abstract].","volume":"98","author":"Reichardt","year":"2001","journal-title":"Blood."},{"key":"2019111616325228100_B12","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1182\/blood.V99.5.1745","article-title":"Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells.","volume":"99","author":"Zhan","year":"2002","journal-title":"Blood."},{"key":"2019111616325228100_B13","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1073\/pnas.050587197","article-title":"Activation of antitumor cytotoxic T lymphocytes by fusions of human dendritic cells and breast carcinoma cells.","volume":"97","author":"Gong","year":"2000","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2019111616325228100_B14","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1182\/blood.V99.7.2512","article-title":"Immunization against murine multiple myeloma with fusions of dendritic and plasmacytoma cells is potentiated by interleukin 12.","volume":"99","author":"Gong","year":"2001","journal-title":"Blood."},{"key":"2019111616325228100_B15","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1084\/jem.184.2.465","article-title":"Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo.","volume":"184","author":"Boczkowski","year":"1996","journal-title":"J Exp Med."},{"key":"2019111616325228100_B16","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1084\/jem.186.7.1177","article-title":"Bone marrow-generated dendritic cells pulsed with tumor extracts or tumor RNA induce antitumor immunity against central nervous system tumors.","volume":"186","author":"Ashley","year":"1997","journal-title":"J Exp Med."},{"key":"2019111616325228100_B17","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/nbt0498-364","article-title":"Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA.","volume":"16","author":"Nair","year":"1998","journal-title":"Nat Biotechnol."},{"key":"2019111616325228100_B18","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/(SICI)1097-0215(19990702)82:1<121::AID-IJC20>3.0.CO;2-X","article-title":"Induction of carcinoembryonic antigen (CEA)-specific cytotoxic T-lymphocyte responses in vitro using autologous dendritic cells loaded with CEA peptide or CEA RNA in patients with metastatic malignancies expressing CEA.","volume":"82","author":"Nair","year":"1999","journal-title":"Int J Cancer."},{"key":"2019111616325228100_B19","doi-asserted-by":"crossref","first-page":"5508","DOI":"10.4049\/jimmunol.164.10.5508","article-title":"Human dendritic cells transfected with RNA encoding prostate-specific antigen stimulate prostate-specific CTL responses in vitro.","volume":"164","author":"Heiser","year":"2000","journal-title":"J Immunol."},{"key":"2019111616325228100_B20","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/00002371-200007000-00004","article-title":"Induction of cytotoxic T lymphocytes with dendritic cells transfected with human papillomavirus E6 and E7 RNA: implications for cervical cancer immunotherapy.","volume":"23","author":"Thornburg","year":"2000","journal-title":"J Immunother."},{"key":"2019111616325228100_B21","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/79519","article-title":"Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells.","volume":"6","author":"Nair","year":"2000","journal-title":"Nat Med."},{"key":"2019111616325228100_B22","first-page":"3388","article-title":"Human dendritic cells transfected with renal tumor RNA stimulate polyclonal T-cell responses against antigens expressed by primary and metastatic tumors.","volume":"61","author":"Heiser","year":"2001","journal-title":"Cancer Res."},{"key":"2019111616325228100_B23","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.4049\/jimmunol.166.5.2953","article-title":"Induction of polyclonal prostate cancer-specific CTL using dendritic cells transfected with amplified tumor RNA.","volume":"166","author":"Heiser","year":"2001","journal-title":"J Immunol."},{"key":"2019111616325228100_B24","doi-asserted-by":"crossref","first-page":"4238","DOI":"10.1182\/blood.V92.11.4238","article-title":"Generation of functional human dendritic cells from adherent peripheral blood monocytes by CD40 ligation in the absence of granulocyte-macrophage colony-stimulating factor.","volume":"92","author":"Brossart","year":"1998","journal-title":"Blood."},{"key":"2019111616325228100_B25","first-page":"732","article-title":"Her-2\/neu-derived peptides are tumor-associated antigens expressed by human renal cell and colon carcinoma lines and are recognized by in vitro induced specific cytotoxic T lymphocytes.","volume":"58","author":"Brossart","year":"1998","journal-title":"Cancer Res."},{"key":"2019111616325228100_B26","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1182\/blood.V93.12.4309","article-title":"Identification of HLA-A2-restricted T-cell epitopes derived from the MUC1 tumor antigen for broadly applicable vaccine therapies.","volume":"93","author":"Brossart","year":"1999","journal-title":"Blood."},{"key":"2019111616325228100_B27"},{"key":"2019111616325228100_B28","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0301-472X(00)00619-6","article-title":"Dendritic cells derived from multiple myeloma patients efficiently internalize different classes of myeloma protein.","volume":"29","author":"Butch","year":"2001","journal-title":"Exp Hematol."},{"key":"2019111616325228100_B29","first-page":"6846","article-title":"The epithelial tumor antigen MUC1 is expressed in hematological malignancies and is recognized by MUC1-specific cytotoxic T-lymphocytes.","volume":"61","author":"Brossart","year":"2001","journal-title":"Cancer Res."},{"key":"2019111616325228100_B30","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1182\/blood.V96.8.2828","article-title":"Tumor-specific recognition of human myeloma cells by idiotype-induced CD8+ T cells.","volume":"96","author":"Li","year":"2000","journal-title":"Blood."},{"key":"2019111616325228100_B31","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1182\/blood.V97.6.1750","article-title":"Idiotype-specific cytotoxic T lymphocytes in multiple myeloma: evidence for their capacity to lyse autologous primary tumor cells.","volume":"97","author":"Wen","year":"2001","journal-title":"Blood."},{"key":"2019111616325228100_B32","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/76243","article-title":"Immunoglobulin framework-derived peptides function as cytotoxic T-cell epitopes commonly expressed in B-cell malignancies.","volume":"6","author":"Trojan","year":"2000","journal-title":"Nat Med."},{"key":"2019111616325228100_B33","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1182\/blood.V73.2.566.566","article-title":"Phenotypic analysis of human myeloma cell lines.","volume":"73","author":"Duperray","year":"1989","journal-title":"Blood."},{"key":"2019111616325228100_B34","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.4049\/jimmunol.153.5.2102","article-title":"Expression of MUC1 on myeloma cells and induction of HLA-unrestricted CTL against MUC1 from a multiple myeloma patient.","volume":"153","author":"Takahashi","year":"1994","journal-title":"J Immunol."},{"key":"2019111616325228100_B35","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1182\/blood.V93.4.1287","article-title":"Muc-1 core protein is expressed on multiple myeloma cells and is induced by dexamethasone.","volume":"93","author":"Treon","year":"1999","journal-title":"Blood."},{"key":"2019111616325228100_B36","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.4049\/jimmunol.160.5.2139","article-title":"Differential presentation of the same MHC class I epitopes by fibroblasts and dendritic cells.","volume":"160","author":"Butz","year":"1998","journal-title":"J Immunol."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/101\/3\/977\/1259343\/h80303000977.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/101\/3\/977\/1259343\/h80303000977.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T17:21:26Z","timestamp":1682356886000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/101\/3\/977\/88850\/Induction-of-myelomaspecific-cytotoxic-T-cells"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,2,1]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2003,2,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2002-04-1273","relation":{},"ISSN":["1528-0020","0006-4971"],"issn-type":[{"value":"1528-0020","type":"electronic"},{"value":"0006-4971","type":"print"}],"subject":[],"published":{"date-parts":[[2003,2,1]]}}}